|
DCAF11 expression based on
|
| Comparison | Statistical significance |
| Normal-vs-Primary | 2.18958184916573E-12 |
|
Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Stage1 |
3.36659589095234E-11 |
| Normal-vs-Stage2 |
1.316030E-03 |
| Normal-vs-Stage3 |
4.36983782492462E-13 |
| Normal-vs-Stage4 |
1.20700116568173E-11 |
| Stage1-vs-Stage2 |
1.579660E-02 |
| Stage1-vs-Stage3 |
7.172200E-02 |
| Stage1-vs-Stage4 |
4.806400E-02 |
| Stage2-vs-Stage3 |
5.021300E-04 |
| Stage2-vs-Stage4 |
3.956500E-04 |
| Stage3-vs-Stage4 |
5.538000E-01 |
|
|
Note
Patient race information is not available for 92 samples and one samples from American Indians not included in the above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Caucasian |
6.18394224716212E-14 |
| Normal-vs-AfricanAmerican |
1.838700E-04 |
| Normal-vs-Asian |
9.21260000508184E-08 |
| Caucasian-vs-AfricanAmerican |
3.843600E-01 |
| Caucasian-vs-Asian |
2.284600E-01 |
| AfricanAmerican-vs-Asian |
9.104800E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Male |
1.59959823164968E-11 |
| Normal-vs-Female |
8.2359674635768E-12 |
| Male-vs-Female |
3.061000E-01 |
|
|
Note
Seventeen samples from patient below 21 years not considered in above plot.
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-Age(21-40Yrs) |
6.09959860398135E-11 |
| Normal-vs-Age(41-60Yrs) |
7.43230033073417E-10 |
| Normal-vs-Age(61-80Yrs) |
8.25084445210678E-12 |
| Normal-vs-Age(81-100Yrs) |
4.398400E-04 |
| Age(21-40Yrs)-vs-Age(41-60Yrs) |
7.274800E-01 |
| Age(21-40Yrs)-vs-Age(61-80Yrs) |
4.712200E-01 |
| Age(21-40Yrs)-vs-Age(81-100Yrs) |
5.781600E-01 |
| Age(41-60Yrs)-vs-Age(61-80Yrs) |
3.134800E-01 |
| Age(41-60Yrs)-vs-Age(81-100Yrs) |
5.254000E-01 |
| Age(61-80Yrs)-vs-Age(81-100Yrs) |
7.540600E-01 |
|
|
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Classical-VS-Tall |
1.84315999999241E-05 |
| Classical-VS-Follicular |
6.288800E-01 |
| Classical-VS-Other |
9.427700E-02 |
| Classical-VS-Normal |
8.90465479130853E-12 |
| Tall-VS-Follicular |
1.023760E-04 |
| Tall-VS-Other |
8.533800E-01 |
| Tall-VS-Normal |
1.21014309684142E-14 |
| Follicular-VS-Other |
1.403750E-01 |
| Follicular-VS-Normal |
1.5059000000317E-06 |
| Other-VS-Normal |
6.40149999999728E-05 |
|
|
Note
Cancer in nearby lymph nodes cannot be measured (NX) in 50 samples.
| pathologic_N descriptions |
| N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
| N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
| Comparison |
Statistical significance |
| Normal-vs-N0 |
4.39250003037017E-09 |
| Normal-vs-N1 |
2.42028619368284E-14 |
| N0-vs-N1 |
1.354240E-04 |
|
|
